PMID- 28752716 OWN - NLM STAT- MEDLINE DCOM- 20190513 LR - 20230805 IS - 1008-9292 (Print) IS - 1008-9292 (Linking) VI - 46 IP - 2 DP - 2017 Mar 25 TI - [Progress on mechanisms for pathogensto evade NOD-like receptor and Toll-like receptor signaling pathways]. PG - 218-224 AB - The innate immune system provides a first line of defense against invading pathogens, in which the pattern recognition receptors (PRR) recognize pathogen-associated molecular patterns (PAMP) and initiate the downstream signaling pathways to eliminate the encountered pathogens. There are two main classes of such signaling pathways: NOD-like receptor (NLR) signaling pathway and Toll-like receptor (TLR) signaling pathway. The microbial pathogens under selective pressure have evolved numerous mechanisms to avoid and/or manipulate the NLR and TLR signal transduction for survival and replication. To evade the NLR signaling pathway, pathogens interfere and/or inhibit inflammasome activation in innate immune cells by producing virulence factors or reducing PAMPs expression. The mechanisms for pathogens to evade TLR signaling pathway include: inhibition of mitogen activated protein kinases (MAPKs) cascade reaction, inhibition of NF-capital KA, CyrillicB activation, and interference of down-stream signal transduction by producing Toll/interleukin-1 receptor (TIR)-containing proteins which bind directly with TLRs or adaptor proteins in the signaling pathway. FAU - Yujie, H E AU - Yujie HE AD - School of Medicine, Zhejiang University City College, Hangzhou 310015, China; Department of Medical Microbiology and Parasitology, Zhejiang University School of Medicine, Hangzhou 310058, China. FAU - Jianping, Pan AU - Jianping P AD - School of Medicine, Zhejiang University City College, Hangzhou 310015, China. jppan@zucc.edu.cn. LA - chi PT - Journal Article PL - China TA - Zhejiang Da Xue Xue Bao Yi Xue Ban JT - Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences JID - 100927946 RN - 0 (NLR Proteins) RN - 0 (Receptors, Interleukin-1) RN - 0 (Toll-Like Receptors) SB - IM MH - *Immunity, Innate MH - *NLR Proteins/immunology MH - Receptors, Interleukin-1/metabolism MH - *Signal Transduction MH - *Toll-Like Receptors/immunology PMC - PMC10396992 EDAT- 2017/07/29 06:00 MHDA- 2019/05/14 06:00 PMCR- 2017/04/25 CRDT- 2017/07/29 06:00 PHST- 2017/07/29 06:00 [entrez] PHST- 2017/07/29 06:00 [pubmed] PHST- 2019/05/14 06:00 [medline] PHST- 2017/04/25 00:00 [pmc-release] AID - zjdxxbyxb-46-2-218 [pii] AID - 10.3785/j.issn.1008-9292.2017.04.16 [doi] PST - ppublish SO - Zhejiang Da Xue Xue Bao Yi Xue Ban. 2017 Mar 25;46(2):218-224. doi: 10.3785/j.issn.1008-9292.2017.04.16.